Optimization and Data Visualization of Applied Proteogenomics Organizational Learning and Outcomes (APOLLO) Pathology Data

Optimization and Data Visualization of Applied Proteogenomics OrganizationaL Learning and Outcomes (APOLLO) Pathology Data Alex Seagal, MS1, Brenda Deyarmin2, Alina Ciubotaru1, Leonard Blake1, Kimberly N Murtha2, Justin M. Wells, MD3, Renata B. Greenspan, MD3, Leigh Campbell, MS3,4, Jesse Stratton2, Nicole L. Wolf, MS3, APOLLO Research Network, Craig D. Shriver, COL (Ret), MD3, Leonid Kvecher, MS2, Hai Hu, Ph.D2 1 Seagal Solutions, Inc., Philadelphia, PA, 2 Chan Soon-Shiong Institute of Molecular Medicine at Windber, Windber, PA, 3 Murtha Cancer Center Research Program, Department of Surgery, Uniformed Services University of the Health Sciences, Bethesda, MD, 4 Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, MD The contents of this publication are the sole responsibility of the author(s) and do not necessarily reflect the views, opinions, or policies of USUHS, HJF, the DoD or the Departments of the Army, Navy or Air Force. Mention of trade names, commercial products, or organizations does not imply endorsement by the U.S. Government. Figure 3: CAP eCC DW Report Data INTRODUCTION METHODS Every year cancer affects more than 1,000 active-duty military personnel which directly and adversely affects the readiness of the armed forces. The Department of Defense (DoD), the Department of Veterans Affairs (VA), and the National Cancer Institute (NCI) formed the Applied Proteogenomics Organizational Learning and Outcomes (APOLLO) Consortium as part of the Cancer Moonshot Program. The objectives of APOLLO are to detect, intervene, and more rapidly identify the unique targets and pathways of cancer, which are clinically actionable and transformative. PURPOSE STATEMENT The Department of Defense, Veterans Health Administration, and multiple civilian medical centers provide data along with tissue and blood samples for APOLLO research. Data is collected utilizing an in-house developed Data Tracking System for the APOLLO program (DTS-APOLLO) to track b
RITM0040049
Every year cancer affects more than 1,000 active-duty military personnel which directly and adversely affects the readiness of the armed forces. The Department of Defense (DoD), the Department of Veterans Affairs (VA), and the National Cancer Institute (NCI) formed the Applied Proteogenomics Organizational Learning and Outcomes (APOLLO) Consortium as part of the Cancer Moonshot Program. The objectives of APOLLO are to detect, intervene, and more rapidly identify the unique targets and pathways of cancer, which are clinically actionable and transformative.